180 related articles for article (PubMed ID: 26819081)
1. Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.
Zhang M; Wu C; Li B; Du W; Zhang C; Chen Z
Cancer Med; 2016 Apr; 5(4):760-6. PubMed ID: 26819081
[TBL] [Abstract][Full Text] [Related]
2. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X
PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
[TBL] [Abstract][Full Text] [Related]
4. Single-nucleotide gene polymorphisms involving cell death pathways: a study of Chinese patients with lumbar disc herniation.
Sun Z; Ling M; Chang Y; Huo Y; Yang G; Ji Y; Li Y
Connect Tissue Res; 2013; 54(1):55-61. PubMed ID: 23205884
[TBL] [Abstract][Full Text] [Related]
5. Fas and FasL polymorphisms are not associated with acute myeloid leukemia risk in Koreans.
Kim HJ; Jin XM; Kim HN; Lee IK; Park KS; Park MR; Jo DY; Won JH; Kwak JY; Kim HJ; Choi JS; Juhng SW; Choi C
DNA Cell Biol; 2010 Oct; 29(10):619-24. PubMed ID: 20438363
[TBL] [Abstract][Full Text] [Related]
6. Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis.
Huang D; Xiao J; Deng X; Ma K; Liang H; Shi D; Wu F; Shao Z
BMC Musculoskelet Disord; 2018 May; 19(1):137. PubMed ID: 29734947
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.
Shao P; Ding Q; Qin C; Wang M; Tang J; Zhu J; Chen J; Cao Q; Li J; Xu B; Zhang Z; Zhang W; Yin C
Prostate; 2011 Jul; 71(10):1122-30. PubMed ID: 21557277
[TBL] [Abstract][Full Text] [Related]
8. Fas/FasL, Bcl2 and Caspase-8 gene polymorphisms in Chinese patients with rheumatoid arthritis.
Zhu A; Wang M; Zhou G; Zhang H; Liu R; Wang Y
Rheumatol Int; 2016 Jun; 36(6):807-18. PubMed ID: 26905515
[TBL] [Abstract][Full Text] [Related]
9. Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.
Wang J; Gao J; Li Y; Zhao X; Gao W; Peng L; Yan D; Liu L; Li D; Wei L; Qi J; Zhou C
Gene; 2013 Jul; 524(2):193-6. PubMed ID: 23618817
[TBL] [Abstract][Full Text] [Related]
10. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
Yıldır S; Sezgin M; Barlas IÖ; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
Rheumatol Int; 2013 Oct; 33(10):2637-45. PubMed ID: 23749041
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
[TBL] [Abstract][Full Text] [Related]
12. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.
Xu Y; He B; Li R; Pan Y; Gao T; Deng Q; Sun H; Song G; Wang S
PLoS One; 2014; 9(3):e90090. PubMed ID: 24598538
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
[TBL] [Abstract][Full Text] [Related]
14. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.
Zhao H; Chen W; Du P; Sun A; Zhuang C; Tong J; Wang L
Tumour Biol; 2015 Jun; 36(6):4319-26. PubMed ID: 25596086
[TBL] [Abstract][Full Text] [Related]
15. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T
Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626
[TBL] [Abstract][Full Text] [Related]
16. FAS and FAS ligand polymorphisms in the promoter regions and risk of gastric cancer in Southern China.
Wang M; Wu D; Tan M; Gong W; Xue H; Shen H; Zhang Z
Biochem Genet; 2009 Aug; 47(7-8):559-68. PubMed ID: 19565204
[TBL] [Abstract][Full Text] [Related]
17. Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.
Hashemi M; Fazaeli A; Ghavami S; Eskandari-Nasab E; Arbabi F; Mashhadi MA; Taheri M; Chaabane W; Jain MV; Łos MJ
PLoS One; 2013; 8(1):e53075. PubMed ID: 23326385
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis-related Fas and FasL gene polymorphisms' associations with knee osteoarthritis.
Sezgin M; Barlas İÖ; Yıldır S; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
Rheumatol Int; 2013 Aug; 33(8):2039-43. PubMed ID: 23392773
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians.
Kupcinskas J; Wex T; Bornschein J; Selgrad M; Leja M; Juozaityte E; Kiudelis G; Jonaitis L; Malfertheiner P
BMC Med Genet; 2011 Aug; 12():112. PubMed ID: 21864388
[TBL] [Abstract][Full Text] [Related]
20. Association between the FAS/FASL polymorphisms and gastric cancer risk: a meta-analysis.
Tian J; Pan F; Li J; Ma Y; Cen H; Pan HF; Pan YY; Ye DQ
Asian Pac J Cancer Prev; 2012; 13(3):945-51. PubMed ID: 22631677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
